Singapore, 6 March 2018 – Verita Healthcare Group Limited (“Verita” or the “Company” and together with its subsidiaries, the “Group”) has made a strategic equity investment in Metabolic Health Solutions Pty Ltd (MHS).

MHS is at the forefront of precision metabolic medicine using a personalised approach to measure, monitor and manage metabolic disease.

Its Precise Metabolic Health™ solutions identify an individual’s unique metabolism and provide tailored nutrition and exercise programs that drive sustainable weight loss. Reducing excess weight helps prevent chronic disorders such as diabetes, cardiovascular disease, chronic fatigue, and neurological conditions.

Verita CEO, Julian Andriesz said: “A healthy metabolism is the foundation for one’s wellness. We are pleased to invest in MHS’ future technologies which complement Verita’s “next generation” healthcare services, comprising personalised, preventative precision medicine that identifies, prevents and reverses disease and extends overall human potential.

We shall be offering MHS’ metabolism optimization solutions at our global Verita Health centres, and through our upcoming Verita Wisdom platform offering mobile health check-ups and assessments for corporations and insurers.”